baber/WOPTO huggingface dataset:
Patent CA-2345105-A1 (CA)
Inventor: PERKIS KRISTIN NICOLE
IPC: C11D17/06
Filed: 1999-09-24
Abstract: Granular detergent composition having an average bulk density of at least about 400 g/L and characterized by a rate of dispersion under stressed cold-water conditions as defined by the equation (1), where R is the residual undispersed detergent at any point in time, t, R is the long term residual undispersed detergent having a value of less than about 14 % of the total amount of an initial dosage of detergent, t is any single point in time, m is a stretching exponent having a value of less than about 2, DT is dispersion time having a value of less than about 0.5 and twash is the time of the wash cycle; and at least 90 % of the insoluble particulate residues of said granular detergent composition having a particle size of less than 15 µm are provided. In preferred embodiments, the detergent composition has a rate of dissolution under stressed cold-water conditions as defined by the equation (2), where U is the fraction of undissolved surfactant at any point in time, t, U is the long term surfactant residual undissolved surfactant having a value of less than about 14 % of the total amount of an initial dosage of surfactant, t is any single point in time, n is a stretching exponent having a value of less than about 2, RT is dissolution time having a value of less than about 0.5 and twash is the time of the wash cycle.
Patent CA-2345243-A1 (CA)
Title: Inhibition of erythrocyte sickling by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester
Inventor: EDMUNDSON ALLEN B
IPC: A61P7/00
Filed: 1999-09-25
Abstract: It has now been found that N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester  (APM) exhibits antisickling properties. In vitro testing verified that APM significantly lowered the frequency of sickling of red blood cells from each  of twelve pediatric aged patients being treated for sickle-cell anemia by exchange transfusion. Sickling was also inhibited in an "index" patient afte r oral administration of APM. These in vitro and in vivo results identify APM as a therapeutic agent for the family of sickle cell molecular diseases.</SDOAB >
Patent CA-2347096-A1 (CA)
Inventor: DATE ROBERT FRANCIS
IPC: A61K8/06
Filed: 1999-06-28
Abstract: The present invention relates to topical compositions for effecting an immediate improvement in the appearance and feel of skin, in addition to providing chronic improvements in skin appearance. The compositions comprise from 0.5 % to 25 % of a first particulate material having a refractive index of from 1.3 to 1.7, the particulate material being dispersed in the composition and having a median particle size of from 2 to 30 µm, and an active effective for chronically regulating skin condition selected from Vitamin B3 compounds, retinoids, and mixtures thereof. Preferred embodiments are oil in water emulsions further comprising a second particulate material having a larger particle size than the first.
Patent CA-2348692-A1 (CA)
Title: Sonde intra-vaginale d'auto-reeducation perineale
Inventor: JUDE PATRICK
IPC: A63B23/20
Filed: 2001-05-25
Abstract: L'invention concerne une sonde Intra-vaginale d'auto-rééducation périnéale. Elle est constituée par un élément (1) de révolution passif et de poids prédéterminé, comprenant - une partie d'extrémité d'introduction arrondie (2), prolongée par, - une partie cylindrique (3) définissant un corps principal, dont les dimensions correspondent sensiblement à l'anneau formé par le système musculaire périnéal, et qui se prolonge par, - une première partie sensiblement tronconique (4), permettant d'obtenir le contrôle de la résistance au poids de l'ensemble de l'élément (1), et qui se prolonge par, - une seconde partie sensiblement tronconique (5), évasée dans une direction opposée à ladite première partie tronconique (4), définissant avec celle-ci une zone centrale concave de révolution (6), et qui se prolonge par, - une partie externe formant un anneau permettant une préhension manuelle de l'élément (1), et évitant la migration de ce dernier dans le vagin.
Patent CA-2351955-A1 (CA)
Title: Firearm inspection and unloading containment device
Inventor: SWAN IAN
IPC: F41J13/00
Filed: 2001-06-28
Abstract: A ballistic projectile containment device includes a housing, a sleeve mounted in the housing to thereby define a cavity, and swatches of ballistic material filling the cavity to an effective thickness. The housing may be an elongate housing having a longitudinal axis and only one open end so as to define a cavity opening from the open end and extending into the housing. The sleeve may be a substantially rigid, hollow sleeve having only one opening, the sleeve mounted into the open end and extending into the cavity along the longitudinal axis. The sleeve is sized smaller than the cavity so as to define a ballistic material receiving portion of the cavity between the sleeve and the housing. The ballistic material receiving portion of the cavity is filled with unbonded swatches of ballistic material and of sufficient depth parallel to the longitudinal axis so as to contain within the housing a ballistic projectile fired into the sleeve from a weapon held substantially within an opening of the sleeve and aligned relative to the sleeve so as to align a trajectory of the fired projectile substantially parallel with the longitudinal axis.
Patent CA-2354185-A1 (CA)
Inventor: WEBB STEVEN R
IPC: C12N15/31
Filed: 1999-12-22
Abstract: Des produits de synthèse génétique, des vecteurs de transformation et des procédés de transformation sont présentés pour la production de plantes transgéniques qui peuvent être sélectivement retirées d'un site de croissance par application d'un agent chimique ou d'une contrainte physiologique. Cette invention associe un gène cible pour sa caractéristique d'intérêt commercial à un gène létal sous conditions, qui peut être sélectivement exprimé pour provoquer la mort végétale. En utilisant ces produits de synthèse génétique, ces vecteurs de transformation et ces procédés de transformation, on peut éviter l'invasion de milieux ambiants et la contamination de productions commerciales non modifiées génétiquement de la part de plantes transgéniques. Des procédés sont présentés pour la transformation de l'espèce Brassica.
Patent CA-2354336-A1 (CA)
Inventor: FAIVRE DAMIEN
IPC: A01D67/00
Filed: 2001-07-30
Abstract: An implement draft tongue is moved through a range of working positions to a transport position extending transverse to the working direction of the implement by an extensible and retractable hydraulic actuator. A control for the hydraulic cylinder includes an interrupter valve that is actuated, in response to a preselected extension of the hydraulic cylinder so as to prevent the cylinder from extending beyond a position for moving the draft tongue to one extreme of its operating range, when an actuating device for the interrupt valve is enabled. When the actuating device for the interrupt valve is disabled, the hydraulic actuator may be extended fully to place the draft tongue in its transport position.
Patent CA-2355237-A1 (CA)
Title: A system for cleaning contact lenses
Inventor: BRUUN-JENSEN JORGEN
IPC: A61J1/14
Filed: 1999-12-14
Abstract: A container means suitable for holding at least one substance for use in a process for cleaning contact lenses using a fluid, the container means comprising: at least one first and at least one second part assembled/combin ed to form a sealed cavity for holding the at least one substance, the second part(s) being formed of a material having a second expansion coefficient whe n embedded in the fluid and being at least substantially insoluble in the flui d, the second part(s) having outer surface(s) constituting part(s) of an outer surface of the container means, the first part(s) being formed of a material  having a first expansion coefficient when embedded in the fluid and being at  least substantially insoluble in the fluid. The container means being characterised in that it further comprises orientation means for orientation  of the container means relative to the horizontal direction when positioned in a receptacle adapted to hold the container means, the contact lenses, and th e fluid during cleaning of the contact lenses.
Patent CA-2356213-A1 (CA)
Title: Melt processing of an elastomeric olefin polymer
Inventor: WRESCHINSKY MICHAEL
IPC: B29C48/875
Filed: 2000-01-18
Abstract: A method to melt process a thermoplastic, partially-crystalline, olefin polymer in a multi-temperature stage extruder wherein the polymer has a broad melting temperature range comprises setting the temperature profile of the extruder such that a portion of the polymer crystallizes in the extruder and passing the resulting partially-crystallized polymer through an extruder die.
Patent CA-2356465-A1 (CA)
Title: Thermoelectric material and method of manufacturing the same
Inventor: SUZUKI AKIKO
IPC: C23C14/28
Filed: 2001-09-04
Abstract: A thermoelectric material having large thermoelectric figure of merit is provided. A thin film comprising manometer-sized particles having their diameters distributing within the range of 0.5 nm though 100 nm both inclusive is formed by depositing the manometer-sized particles on a substrate, or dispersing the particles in a solid matrix material or solution thereby to form a thin film. In the thin film, a band gap due to quantum confinement effect is generated in each of the particles and electrical conduction occurs by that at least a part of the particles supply carriers. Accordingly, thermal conductivity K as well as electrical resistivity p and Seebeck coefficient S all of which are factors of thermoelectric figure of merit can be independently controlled, and it is possible to get a thermoelectric material having large dimensionless thermoelectric figure of merit ZT such as beyond 1.5.
Patent CA-2358994-A1 (CA)
Title: Pipe coupling for plastic pipes
Inventor: CARLSTROEM BORGE
IPC: B29C41/52
Filed: 2000-01-19
Abstract: The invention relates to a pipe coupling for plastic pipes which comprises a glass-fiber reinforced plastic sleeve (2) and a membrane (4) which is produced from an elastic material. Said membrane is configured as a seal on at least one side and is provided with a jointing sleeve (8). In that portion of the membrane where it is configured as a seal, a short section (14) is shaped cylindrically at the margin of the membrane where the tube (20) is inserted (that is at the outer end of the membrane). In said cylindrical part the membrane has a constant wall thickness on which the glass-fiber reinforced sleeve part of the pipe coupling comes to rest.
Patent CA-2359561-A1 (CA)
Title: Proteasome inhibitors
Inventor: YAMAGUCHI HIROYUKI
IPC: C07C271/22
Filed: 2000-01-20
Abstract: Proteasome inhibitors containing as the active ingredient carboxylic acid derivatives represented by general formula (I) or pharmacologically acceptab le salts thereof: wherein m and n are each independently an integer of 0 to 10;  p is 0 or 1; R1 is hydrogen, substituted or unsubstituted alkyl, substituted o r unsubstituted cycloalkyl, or the like; and R2 is hydrogen, COR13 or CH2OR3a,  or alternatively R1 and R2 together represent formula (II), wherein X1 is a linkage, substituted or unsubstituted alkylene, substituted or unsubstituted  cycloalkylene, or the like; X2 is oxygen, sulfur, or NR17; R3 is as defined for R3a; and R4 is hydroxyl, mercapto, substituted or unsubstituted alkoxy, or the like, or alternatively R3 and R4 together represent a linkage; and R5 is  hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, or the like.
Patent CA-2360232-A1 (CA)
Title: Telomerase inhibitors
Inventor: AKAMA TSUTOMU
IPC: A61K31/409
Filed: 2000-01-12
Abstract: Telomerase inhibitors containing as the active ingredient porphyrin derivatives represented by general formula (I), N-(lower alkyl)-substituted derivatives thereof (wherein the lower alkyl is located on the nitrogen atom of the pyrrole ring of the porphyrin ring) or metal coordinates thereof or pharmacologically acceptable salts thereof: (I) wherein R1, R2, R3, R4, R5, R6, R7 and R8 are the same or different and each represents hydrogen, formyl, optionally substituted lower alkyl, optionally substituted lower alkenyl, carboxy, optionally substituted lower alkoxycarbonyl, CONR9R10 (wherein R9 and R10 are the same or different and each represents hydrogen or optionally substituted lower alkyl), sulfo, lower alkoxysulfonyl or cyano.
Patent CA-2361893-A1 (CA)
Title: Polymerizable compound, polymerizable liquid crystal composition containing the same, and optically anisotropic medium made from the composition
Inventor: HASEBE HIROSHI
IPC: C09K19/20
Filed: 2001-11-13
Abstract: A polymerizable compound represented by formula (I): (see formula I) wherein Q1 and Q2 each independently represent a hydrogen atom or a methyl group; p and q each independently represent an integer of 2 to 18; X1 and X2 each independently represent a single bond, -O-, -COO- or -OCO-; L1 represents -COO- or -OCO-; L2 represents -CH2CH2COO- or -CH2CH2OCO-; and Y1, Y2 and Y3 each independently represent a hydrogen atom, an alkyl group having 1 to 7 carbon atoms, an alkoxy group having 1 to 7 carbon atoms, an alkanoyl group having 2 to 7 carbon atoms, a cyano group or a halogen atom. Also disclosed are a polymerizable liquid crystal composition containing the compound, and an optically anisotropic medium produced from the composition.
Patent CA-2365970-A1 (CA)
Title: Chemokine-derived synthetic peptides
Inventor: LUO JIANSONG
IPC: C07K14/52
Filed: 2000-04-06
Abstract: Synthetic peptide analogs of chemokines are designed to include the N- and C-terminal portions of the corresponding naturally occurring chemokine. In particular, synthetic peptide analogs of stromal cell-derived factor-1 (SDF-1) are effective in inhibiting HIV-1 entry and infection via the CXC chemokine receptor 4 (CXCR4). Each peptide comprises a peptide segment analog of the SDF-1 N-terminal region joined to a peptide segment analog of the SDF-1 C-terminal region. The peptides are useful for HIV treatment and prophylaxis.
Patent CA-2369117-A1 (CA)
Inventor: CHATANI MASAYUKI
IPC: H04W4/06
Filed: 2000-04-11
Abstract: A database communication network system has an entertainment system (12) comprising an entertainment apparatus (102) to which a portable information communication terminal (32) is detachably connected. An individual identification code (individual PDA ID) of the portable information communication terminal (32) and a service request are transmitted from the entertainment system (12) via a bidirectional communication network (16) to a computer system (20) having a server function. The computer system (20) transmits a command representing the individual PDA ID and the service reque st via a link (22) in the form of a LAN to a computer system (24) having a database. The computer system (24) searches a database to extract informatio n corresponding to a service request, and transmits (broadcasts) the extracted  information together with the individual PDA ID via a wireless unidirectiona l communication network (28) and a link (30) to the portable information communication terminal (32). Only the portable information communication terminal (32) with the individual PDA ID is capable of reproducing the received data.
Patent CA-2369997-A1 (CA)
Inventor: KONG XIANQI
IPC: A61K31/192
Filed: 2000-04-28
Abstract: Therapeutic compounds and methods for modulating amyloid aggregation in a subject, whatever its clinical setting, are described. Amyloid aggregation is modulated by the administration to a subject of an effective amount of a therapeutic compound of formula (1) or a pharmaceutically acceptable salt or ester, such that modulation of amyloid aggregation occurs. R1 and R2 are each independently a hydrogen atom or a substituted or unsubstituted aliphatic or aryl group. Z and Q are each independently a carbonyl (C=O), thiocarbonyl (C=S), sulfonyl (SO2), or sulfoxide (S=O) group. "k" and "m" are 0 or 1, provided when k is 1, R1 is not a hydrogen atom, and when m is 1, R2 is not a hydrogen atom. In an embodiment, at least one of k or m must equal 1. "p" and "s" are each independently positive integers selected such that the biodistribution of the therapeutic compound for an intended target site is not prevented while maintaining activity of the therapeutic compound. T is a linking group and Y is a group of the formula: -A X, wherein A is an anionic group at physiological pH, and X is a cationic group.
Patent CA-2370562-A1 (CA)
Inventor: RUBEN STEVEN M
IPC: C07K14/47
Filed: 2000-04-06
Abstract: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.
Patent CA-2371654-A1 (CA)
Title: System and method for parallel connection selection in a communication network
Inventor: PRAGER WALTER
IPC: H04L12/56
Filed: 2002-02-13
Abstract: The invention provides a system and method of a selecting an egress connection from egress connections at a node for a call being established in a network along a path being associated with the node. The invention determines which connections have sufficient bandwidth to carry the call and which connections have a service category being compatible with a service requirement for the call. For connections which are able to carry the call, the invention evaluates an administrative factor score for each connection, then if one score for a particular connection is superior to all other scores, the particular connection is selected as the egress connection. Otherwise, if at least two administrative factor scores are equally superior to all other administrative factor scores, then the egress connection is selected from the connections having the equally superior scores utilizing a bandwidth load balance value for those connections.
Patent CA-2375139-A1 (CA)
Inventor: FURUSHO SHINJI
IPC: G06F17/30
Filed: 2000-05-30
Abstract: Les données du tableau sont divisées en un ou plusieurs blocs constitués chacun d'une liste de valeurs dans laquelle les valeurs appartenant à des articles spécifiques sont mémorisées dans l'ordre du numéro de valeur d'article correspondant à la valeur de l'article et d'un ensemble de pointeurs où les valeurs de pointeurs servant à spécifier les numéros des valeurs d'articles sont mémorisées dans l'ordre d'un numéro d'enregistrement unique. Afin de combiner les données du tableau, on cherche les articles équivalents parmi ces données, et on spécifie les cases concernant des articles équivalents. On compare ensuite les listes de valeurs incluses dans les cases du tableau spécifiées les unes avec les autres, et on égalise les valeurs des deux listes de valeurs. Une fois cette égalisation réalisée, on ajoute les valeurs des pointeurs de l'ensemble de pointeurs associé dans la case où l'on ajoute la valeur de l'article. Enfin, on rend les listes de valeurs comprises dans les cases concernant des articles spécifiques équivalentes les unes aux autres parmi les données du tableau.
Patent CA-2375147-A1 (CA)
Inventor: NEUBERGER JAMES
IPC: A61K48/00
Filed: 2000-06-01
Abstract: L'invention porte premièrement sur la découverte, l'identification et la caractérisation de nouvelles molécules associées à la PBC, au syndrome de Sjögren's, à la sclérodermie, au SLE (lupus érythémateux aigu disséminé), à la thyroïdite auto-immune, et à divers autres troubles des tissus conjonctifs. Ces nouvelles séquences de nucléotides sont d'origine rétrovirale et indicatrices de la présence d'un rétrovirus de la PBC présentant une forte corrélation avec la PBC. Ladite invention se fonde en partie sur des données des déposants, premières constatations suggérant que les tissus d'un patient atteint de PBC pouvaient abriter un agent transmissible. L'association d'agents infectieux rétroviraux à la PBC a d'abord été démontrée <i>in vitro</i> par les déposants par une co-culture de ganglions lymphatiques périportes prélevés sur le patient lors de la transplantation, et de cellules saines d'épithélium biliaire. Les découvertes des déposants exposées dans la description mentionnent que l'agent infectieux associé à la PBC à un caractère rétroviral, comme cela a été démontré par le microscope électronique et la réactivité de l'immunoblot. Les déposants ont en outre caractérisé de nouvelles séquences nucléotidiques associées au rétrovirus associé à la PBC.
Patent CA-2375515-A1 (CA)
Inventor: TAYLOR DAVID STIRLING
IPC: A41D31/00
Filed: 2000-07-13
Abstract: A flexible material comprises a plurality of separate resilient elements (1) joined to a flexible, resiliently stretchable substrate (2). Such a material is suitable for providing protective wear for human and animal bodies. Preferably, the elements comprise a foam material such as a closed cell polyethylene foam and the substrate comprises a knitted fabric. In an advantageous embodiment, a second flexible substrate is bonded over the elements (1) to sandwich them between the two layers of substrate (2).
Patent CA-2378640-A1 (CA)
Title: Equipment and method in handling of doctor blades for a paper/cardboard machine
Inventor: ESKELINEN ILKKA
IPC: D21G3/00
Filed: 2000-06-15
Abstract: The present invention relates to an equipment for reeling used doctor blades to be in storable form for reuse, after--treatment or recycling of doctor blades. The equipment comprises a reeling device (10), provided with a support base (1), a support arm (2), a shaft (9') mounted on the support arm (2), one end whereof being provided with a boss (9) and the other end with a revolving frame (7). In addition, the equipment comprises a transit case (20), within which the used doctor blades (12) can be reeled on a roll. The present invention also relates to a method for handling doctor blades of a paper/cardboard machine, which method comprises the steps from supplying the raw material for doctor blades to the production plant of doctor blades to removing the used doctor blades from the paper/cardboard machine, packing, transporting them away from the paper/cardboard plant and delivering into recycling, reuse or end use.
Patent CA-2379424-A1 (CA)
Title: Slotted slurry take off
Inventor: BOHMER ROBERT W
IPC: B01J8/00
Filed: 2000-07-12
Abstract: Apparatus for removing a concentrated slurry from a flowing stream of slurry in a conduit characterized by a channel in an outlet area of the conduit, the outlet being adapted to continuously remove slurry. In a specific embodiment, an olefin polymerization apparatus is disclosed wherein monomer, diluent and catalyst are circulated in a continuous pipe loop reactor and product slurry is recovered by a continuous product take off means. The pipe has a channel or groove leading to the continuous product take off means. In one embodiment, the slurry is heated in a flash line heater and passed to a high pressure flash where a majority of the diluent is separated and thereafter condensed by simple heat exchange, without compression, and thereafter recycled, bottoms from the high pressure flash being passed to a low pressure flash where polymer is recovered and entrained liquid is flashed overhead. In another embodiment the flash line feeds a single flash chamber.